RESUMEN
Inflammatory responses associated with ischemia/reperfusion injury (IRI) play a central role in alloimmunity and transplant outcomes. A key event driving these inflammatory responses is the burst of reactive oxygen species (ROS), with hydrogen peroxide (H2 O2 ) as the most abundant form that occurs as a result of surgical implantation of the donor organ. Here, we used a syngeneic rat renal transplant and IRI model to evaluate the therapeutic properties of APP-103, a polyoxalate-based copolymer molecule containing vanillyl alcohol (VA) that exhibits high sensitivity and specificity toward the production of H2 O2 . We show that APP-103 is safe, and that it effectively promotes kidney function following IRI and survival of renal transplants. APP-103 reduces tissue injury and IRI-associated inflammatory responses in models of both warm ischemia (kidney clamping) and prolonged cold ischemia (syngeneic renal transplant). Mechanistically, we demonstrate that APP-103 exerts protective effects by specifically targeting the production of ROS. Our data introduce APP-103 as a novel, nontoxic, and site-activating therapeutic approach that effectively ameliorates the consequences of IRI in solid organ transplantation.
Asunto(s)
Trasplante de Riñón , Daño por Reperfusión , Animales , Isquemia , Trasplante de Riñón/efectos adversos , Polímeros , Ratas , Especies Reactivas de Oxígeno , Daño por Reperfusión/tratamiento farmacológico , Daño por Reperfusión/prevención & controlRESUMEN
T-cell immunity undergoes a complex and continuous remodeling with aging. Understanding those dynamics is essential in refining immunosuppression. Aging is linked to phenotypic and metabolic changes in T-cell immunity, many resulting into impaired function and compromised effectiveness. Those changes may impact clinical immunosuppression with evidences suggesting age-specific efficacies of some (CNI and mammalian target of rapamycin inhibitors) but not necessarily all immunosuppressants. Metabolic changes of T cells with aging have only recently been appreciated and may provide novel ways of immunosuppression. Here, we provide an update on changes of T-cell immunity in aging.
Asunto(s)
Envejecimiento , Linfocitos T/citología , Linfocitos T/inmunología , Animales , Inhibidores de la Calcineurina/farmacología , Senescencia Celular , Ensayos Clínicos como Asunto , Supervivencia de Injerto , Humanos , Sistema Inmunológico , Memoria Inmunológica , Terapia de Inmunosupresión , Inmunosupresores/farmacología , Ratones , Fenotipo , Serina-Treonina Quinasas TOR/metabolismo , Células TH1/citología , Células Th2/citología , Receptores de TrasplantesRESUMEN
Magnetic levitation has emerged as a technique that offers the ability to differentiate between cells with different densities. We have developed a magnetic levitation system for this purpose that distinguishes not only different cell types but also density differences in cells of the same type. This small-scale system suspends cells in a paramagnetic medium in a capillary placed between two rare earth magnets, and cells levitate to an equilibrium position determined solely by their density. Uniform reference beads of known density are used in conjunction with the cells as a means to quantify their levitation positions. In one implementation images of the levitating cells are acquired with a microscope, but here we also introduce a cell phone-based device that integrates the magnets, capillary, and a lens into a compact and portable unit that acquires images with the phone's camera. To demonstrate the effectiveness of magnetic levitation in cell density analysis we carried out levitation experiments using red blood cells with artificially altered densities, and also levitated those from donors. We observed that we can distinguish red blood cells of an anemic donor from those that are healthy. Since a plethora of disease states are characterized by changes in cell density magnetic cell levitation promises to be an effective tool in identifying and analyzing pathologic states. Furthermore, the low cost, portability, and ease of use of the cell phone-based system may potentially lead to its deployment in low-resource environments.
Asunto(s)
Teléfono Celular , Índices de Eritrocitos , Eritrocitos/citología , Pruebas Hematológicas/instrumentación , Procesamiento de Imagen Asistido por Computador/instrumentación , Modelos Biológicos , Fotograbar , Anemia Ferropénica/sangre , Anemia Ferropénica/economía , Anemia Ferropénica/patología , Teléfono Celular/economía , Separación Celular/economía , Tamaño de la Célula , Costos y Análisis de Costo , Costos Directos de Servicios , Eritrocitos/química , Eritrocitos/patología , Pruebas Hematológicas/economía , Hemoglobinas/análisis , Humanos , Procesamiento de Imagen Asistido por Computador/economía , Fenómenos Magnéticos , Microscopía/economía , Fotograbar/economía , Pruebas en el Punto de Atención/economíaRESUMEN
PURPOSE OF REVIEW: With global demographic changes and an overall improved healthcare, more older end-stage renal disease (ESRD) patients receive kidney transplants. At the same time, organs from older donors are utilized more frequently. Those developments have and will continue to impact allocation, immunosuppression and efforts improving organ quality. RECENT FINDINGS: Findings mainly outside the field of transplantation have provided insights into mechanisms that drive immunosenescence and immunogenicity, thus providing a rationale for an age-adapted immunosuppression and relevant clinical trials in the elderly. With fewer rejections in the elderly, alloimmune responses appear to be characterized by a decline in effectiveness and an augmented unspecific immune response. SUMMARY: Immunosenescence displays broad and ambivalent effects in elderly transplant recipients. Those changes appear to compensate a decline in allospecific effectiveness by a shift towards an augmented unspecific immune response. Immunosuppression needs to target those age-specific changes to optimize outcomes in elderly transplant recipients.
Asunto(s)
Inmunidad Adaptativa , Senescencia Celular , Inmunidad Innata , Trasplante de Riñón , Animales , Humanos , Tolerancia Inmunológica/inmunología , Fallo Renal Crónico/cirugíaRESUMEN
Donor organ scarcity remains a significant clinical challenge in transplantation. Older organs, increasingly utilized to meet the growing demand for donor organs, have been linked to inferior transplant outcomes. Susceptibility to organ injury, reduced repair capacity, and increased immunogenicity are interrelated and impacted by physiological and pathological aging processes. Insights into the underlying mechanisms are needed to develop age-specific interventional strategies with regards to organ preservation, immunosuppression, and allocation. In this overview, we summarize current knowledge of injury and repair mechanisms and the effects of aging relevant to transplantation.
Asunto(s)
Envejecimiento , Trasplante de Órganos/métodos , Donantes de Tejidos/provisión & distribución , Adulto , Factores de Edad , Anciano , Autofagia , Europa (Continente) , Proteínas de Choque Térmico/metabolismo , Humanos , Isquemia/patología , Trasplante de Riñón/normas , Persona de Mediana Edad , Preservación de Órganos/métodos , Trasplante de Órganos/normas , Complejo de la Endopetidasa Proteasomal/metabolismo , Regeneración , Daño por Reperfusión , Obtención de Tejidos y Órganos , Resultado del Tratamiento , Ubiquitina/metabolismo , Adulto JovenRESUMEN
BACKGROUND: Mechanical injury to the skin by scratching is an important feature of atopic dermatitis (AD). OBJECTIVE: To investigate the role of COX-2 in allergic skin inflammation elicited by epicutaneous (EC) sensitization via introduction of ovalbumin through shaved tape-stripped skin. METHODS: COX-2 mRNA was measured by quantitative PCR, and COX-2 protein was measured by Western blotting. We investigated the effect of administration of the COX-2 selective inhibitor NS-398 during EC sensitization with ovalbumin in a mouse model of AD characterized by eosinophil skin infiltration, elevated total and antigen specific IgE, and a systemic TH2 response to antigen. We further examined the response of COX-2-deficient mice to EC immunization with ovalbumin. RESULTS: Tape stripping caused a transient increase in skin COX-2 mRNA. In contrast, COX-2 mRNA was not increased after ovalbumin sensitization. Infiltration by eosinophils and expression of IL-4 mRNA in ovalbumin-sensitized skin sites, ovalbumin specific IgE and IgG1 antibody responses, and IL-4 secretion by splenocytes after ovalbumin stimulation were all significantly increased in EC mice that received NS-398. In contrast, ovalbumin specific IgG 2a antibody response and IFN-gamma secretion by splenocytes after ovalbumin stimulation were significantly decreased in these mice. COX-2-deficient mice also exhibited an enhanced systemic TH2 response to EC sensitization. CONCLUSION: These results demonstrate that COX-2 limits the TH2 response to EC sensitization and suggest that COX inhibitors may worsen allergic skin inflammation in patients with AD.